These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8953658)

  • 1. Residual symptoms and P300 in schizophrenic outpatients.
    Juckel G; Müller-Schubert A; Gaebel W; Hegerl U
    Psychiatry Res; 1996 Nov; 65(1):23-32. PubMed ID: 8953658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenics with small P300: a subgroup with a neurodevelopmental disturbance and a high risk for tardive dyskinesia?
    Hegerl U; Juckel G; Müller-Schubert A; Pietzcker A; Gaebel W
    Acta Psychiatr Scand; 1995 Feb; 91(2):120-5. PubMed ID: 7778469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P300 subcomponents reflect different aspects of psychopathology in schizophrenia.
    Frodl-Bauch T; Gallinat J; Meisenzahl EM; Möller HJ; Hegerl U
    Biol Psychiatry; 1999 Jan; 45(1):116-26. PubMed ID: 9894583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auditory evoked potentials as possible predictors of outcome in schizophrenic outpatients.
    Hegerl U; Gaebel W; Gutzman H; Ulrich G
    Int J Psychophysiol; 1988 Aug; 6(3):207-14. PubMed ID: 2900230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P300 and symptom improvement in schizophrenia.
    Gallinat J; Riedel M; Juckel G; Sokullu S; Frodl T; Moukhtieva R; Mavrogiorgou P; Nisslé S; Müller N; Danker-Hopfe H; Hegerl U
    Psychopharmacology (Berl); 2001 Oct; 158(1):55-65. PubMed ID: 11685384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between perazine serum concentration and clinical results in long-term treated schizophrenic outpatients (author's transl)].
    Pietzcker A; Müller-Oerlinghausen B; Schley J; Chaskel H; Poppenberg A; Urban R
    Arzneimittelforschung; 1978; 28(8):1302-3. PubMed ID: 37850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and risks of ultra-long-term treatment with an oral neuroleptic drug. Relationship between perazine serum levels and clinical variables in schizophrenic outpatients.
    Pietzcker A; Poppenberg A; Schley J; Müller-Oerlinghausen B
    Arch Psychiatr Nervenkr (1970); 1981; 229(4):315-29. PubMed ID: 6111989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of clozapine on awareness of illness and cognition in schizophrenia.
    Pallanti S; Quercioli L; Pazzagli A
    Psychiatry Res; 1999 Jun; 86(3):239-49. PubMed ID: 10482343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P300 alterations in schizophrenic patients experiencing auditory hallucinations.
    Papageorgiou C; Oulis P; Vasios C; Kontopantelis E; Uzunoglu N; Rabavilas A; Christodoulou GN
    Eur Neuropsychopharmacol; 2004 May; 14(3):227-36. PubMed ID: 15056482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ERPs changes during neuroleptic treatment in schizophrenia--a vulnerability marker in schizophrenia].
    Asato N; Hirayasu Y; Hiramatsu K; Ohta H
    Seishin Shinkeigaku Zasshi; 1999; 101(3):254-76. PubMed ID: 10375977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of P300-amplitudes in the course of schizophrenic disorders.
    Strik WK; Dierks T; Kulke H; Maurer K; Fallgatter A
    J Neural Transm (Vienna); 1996; 103(11):1351-9. PubMed ID: 9013421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State and trait markers of emotionally charged visual event-related potentials (P300) in drug-naïve schizophrenia.
    Mori K; Morita K; Shoji Y; Matsuoka T; Fujiki R; Uchimura N
    Psychiatry Clin Neurosci; 2012 Jun; 66(4):261-9. PubMed ID: 22624730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological performance and auditory event related potentials in schizophrenia patients and their siblings: a family study.
    Şevik AE; Anıl Yağcıoğlu AE; Yağcıoğlu S; Karahan S; Gürses N; Yıldız M
    Schizophr Res; 2011 Aug; 130(1-3):195-202. PubMed ID: 21592733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence of antipsychotic therapy on the cognitive functions of schizophrenic patients].
    Tybura P; Mak M; Samochowiec A; Pełka-Wysiecka J; Grzywacz A; Grochans E; Zaremba-Pechmann L; Samochowiec J
    Psychiatr Pol; 2013; 47(4):567-78. PubMed ID: 24946464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.
    Stefánsson SB; Jónsdóttir TJ
    Biol Psychiatry; 1996 Jul; 40(1):19-27. PubMed ID: 8780851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of auditory event-related P300 amplitude in subjects with at-risk mental state for schizophrenia.
    Ozgürdal S; Gudlowski Y; Witthaus H; Kawohl W; Uhl I; Hauser M; Gorynia I; Gallinat J; Heinze M; Heinz A; Juckel G
    Schizophr Res; 2008 Oct; 105(1-3):272-8. PubMed ID: 18625546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P300 and the thought disorder factor extracted by factor-analytic procedures in schizophrenia.
    Higashima M; Urata K; Kawasaki Y; Maeda Y; Sakai N; Mizukoshi C; Nagasawa T; Kamiya T; Yamaguchi N; Koshino Y
    Biol Psychiatry; 1998 Jul; 44(2):115-20. PubMed ID: 9646893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term olanzapine treatment and p300 parameters in schizophrenia.
    Molina V; Muñoz F; Martín-Loeches M; Casado P; Hinojosa JA; Iglesias A
    Neuropsychobiology; 2004; 50(2):182-8. PubMed ID: 15292675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two syndromes of schizophrenic psychopathology associated with left vs. right temporal deficits in P300 amplitude. Four case reports.
    Shenton ME; Ballinger R; Marcy B; Faux SF; Cane M; Lemay M; Cassens G; Coleman M; Duffy FH; McCarley RW
    J Nerv Ment Dis; 1989 Apr; 177(4):219-25. PubMed ID: 2564883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of clozapine on auditory event-related potentials in schizophrenia.
    Umbricht D; Javitt D; Novak G; Bates J; Pollack S; Lieberman J; Kane J
    Biol Psychiatry; 1998 Oct; 44(8):716-25. PubMed ID: 9798075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.